High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines

Molecular and Cellular Endocrinology

Volumn 116, Issue 1, 1996, Pages 115-119

  Jones, C J ^a   Shaw, J J ^a   Wyllie, F S ^a   Gaillard, N ^b   Schlumberger, M ^b   Wynford Thomas, D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cell cycle; Follicular carcinoma; p16 (INK4a MTS1); Papillary carcinoma; Thyroid; Tumour suppressor genes

Indexed keywords

CYCLIN DEPENDENT KINASE; VIRUS T ANTIGEN;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FOLLICULAR CARCINOMA; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SIMIAN VIRUS 40; SOUTHERN BLOTTING; THYROID CANCER; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; CARRIER PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA PROBES; DNA, NEOPLASM; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; PROTO-ONCOGENE PROTEINS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030031885     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(95)03697-0     Document Type: Article

References (49)

1. Bishop, M.J. (1995) Cancer: the rise of the genetic paradigm. Genes Dev. 9, 1309-1315.
2. Picksley, S.M. and Lane, D.P. (1994) p53 and Rb: their cellular roles. Curr. Opin. Cell Biol. 6, 853-858.
3. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
4. Pines, J. (1995) Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697-711.
5. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev. 9, 1149-1163.
6. Wynford-Thomas, D. (1993) Molecular basis of epithelial tumorigenesis:the thyroid model. Crit. Rev. Oncogen. 4, 1-23.
7. Holm, R. and Nesland, J.M. (1994) Retinoblastoma and p53 tumor suppressor gene protein expression in carcinomas of the thyroid-gland. J. Pathol. 172, 267-272.
8. Zou, M.J., Shi, Y.F. and Farid, N.R. (1994) Frequent inactivation of the retinoblastoma gene in human thyroid carcinomas. Endocr. J. 2, 193-198.
9. Hunter, T. and Pines, J. (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
10. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature 366, 704-707.
11. Koh, J., Enders, G.H., Dynlacht, B.D. and Harlow, E. (1995) Tumour derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
12. INK4 MTS1 tumour suppressor gene product. EMBO J. 14, 503-511.
13. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995) Retinoblastomaprotein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506.
14. Weaver-Feldhaus, J., Gruis, N., Neuhausen, S., Le Paslier, D., Stockert, E., Skolnick, M.H. and Kamb, A. (1994) Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA 91, 7563-7567.
15. Kamb, A. (1995) Cell-cycle regulators and cancer. Trends Genet. 11, 136-140.
16. Yeudall, W.D., Crawford, R., Ensley, J.F. and Robbins, K.C. (1994) MTS1/CDK41 is altered in cell lines derived from primary and metastatic oral squamous carcinoma. Carcinogenesis 15, 2683-2686.
17. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T. and Takahashi, T. (1995) In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res. 55, 514-517.
18. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A.T., Ally, D.S., Sheahan, M.D., Clark, W.H. Jr., Tucker, M.A. and Dracopoli, N.C. (1994) Germline p16 mutations in familial melanoma. Nature Genet. 8, 15-21.
19. Mori, T., Miura, K., Aoki, T., Nishimura, T., Mori, S. and Nakamura, Y. (1994) Frequent somatic mutation of the MTS1/ CDK41 (multiple tumour suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54, 3396-3397.
20. INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11, 405-412.
21. Zhou, X., Tarmin, L., Yin, J., Jiang, H.-Y., Suzuki, H., Rhyu, M.-G., Abraham, J.M. and Meltzer, S.J. (1994) The MTS1 gene family is frequently mutated in primary esophageal tumors. Oncogene 9, 3737-3741.
22. Wynford-Thomas, D. (1993) Molecular genetics of thyroid cancer. Trends Endocrinol. Metab. 4, 224-232.
23. Williams, D.W. and Williams, E.D. (1989) The pathology of follicular thyroid epithelial tumours. In: Thyroid Tumours: Molecular Basis of Pathogenesis (Wynford-Thomas, D. and Williams, E.D., eds.), pp. 57-65, Churchill Livingstone, Edinburgh.
24. Wynford-Thomas, D. (1995) Molecular genetics of thyroid cancer. Curr. Opin. Endocr. Metab., in press.
25. Donghi, R., Longoni, A., Pilotti, S., Michieli, P., Della Porta, G. and Pierotti, M.A. (1993) Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest. 91, 1753-1760.
26. Said, S., Schlumberger, M. and Suarez, H. (1994) Oncogenes and antioncogenes in human epithelial thyroid tumours. J. Endocrinol. Invest. 17, 371-379.
27. Curtis, L., Wyllie, A.H., Shaw, J.J., Williams, G.T., Radulescu, A., DeMicco, C., Haugen, D.R.F., Verhaug, J.E., Lillehaug, J.R. and Wynford Thomas, D. (1994) Evidence against involvement of APC mutation in papillary thyroid carcinoma. Eur. J. Cancer 30A, 984-987.
28. Colletta, G., Sciacchitano, S., Palmirotta, R., Ranieri, A., Zanella, E., Cama, A., Costantini, R.M., Battista, P. and Pontecorvi, A. (1994) Analysis of adenomatous polyposis coli gene in thyroid tumours. Br. J. Cancer 70, 1085-1088.
29. Zeki, K., Spambalg, D., Sharifi, N., Gonsky, R. and Fagin, J. (1994) Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms. J. Clin. Endocrinol. Metab. 4, 159-164.
30. Caldas, C., Hahn, S.A., da Costa, L.T., Redston, M.S., Schutte, M., Seymour, A.B., Weinstein, C.L., Hruban, R.H., Yeo, C.J. and Kern, S.E. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27-32.
31. Leung, H.Y. and Lemoine, N. (1994) Pancreatic cancer. In: Cancer: A Molecular Approach (Lemoine, N., Neoptolemos, J. and Cooke, T., eds.), pp. 105-115, Blackwell Scientific Publications, Oxford.
32. Ledent, C., Marcotte, A., Dumont, J.E., Vassart, G. and Parmentier, M. (1995) Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. Oncogene 10, 1789-1797.
33. Lemoine, N.R., Mayall, E.S., Jones, T., Sheer, D., McDermid, S., Kendall Taylor, P. and Wynford-Thomas, D. (1989) Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br. J. Cancer 60, 897-903.
34. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1994) Current Protocols in Molecular Biology, John Wiley and Sons Inc., New York.
35. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, NY, USA.
36. Allison, J., Hall, L., MacIntyre, I. and Craig, R.K. (1981) The construction and partial characterisation of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem. J. 199, 725-731.
37. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day III, R.S., Johnson, B.E. and Skolnick, M.H: (1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science 264, 436-440.
38. Bonetta, L. (1994) Open questions on p16. Nature 370, 180.
39. Spruck, III C.H., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A.R., Lin, M.-F., Gonzales, F., Tsai, Y.C. and Jones, P.A. (1994) p16 gene in uncultured tumours. Nature 370, 183-184.
40. Wainwright, B. (1994) Familial melanoma and p16: a hung jury. Nature Genet. 8, 3-5.
41. Dawson, T.P., Wyllie, F.S. and Wynford-Thomas, D. (1991) In vitro responsiveness to serum growth factors is inversely related to in vivo malignancy in human thyroid epithelial cells. Br. J. Cancer 63, 897-900.
42. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Natural Med. 1, 686-692.
43. Wright, P.A., Lemoine, N.R., Goretzki, P.E., Wyllie, F.S., Bond, J.A., Hughes, C., Roher, H.-D., Williams, E.D. and Wynford-Thomas, D. (1991) Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene 6, 1693-1697.
44. Fagin, J.A., Matsuo, K., Karmakar, A., Chen, D.L., Tang, S.-H. and Koeffler, H.P. (1993) High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest. 91, 179-184.
45. Fabien, N., Fusco, A., Santoro, M., Barbier, Y., Dubois, P.M. and Paulin, C. (1994) Description of a human papillary thyroid-carcinoma cell line - morphologic study and expression of tumoral markers. Cancer 73, 2206-2212.
46. Wyllie, F.S., Haughton, M.F., Blaydes, J.P., Schlumberger, M. and Wynford-Thomas, D. (1995) Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed epithelial cells. Oncogene 10, 49-59.
47. White, E. (1994) p53, guardian of RB. Nature 371, 21-22.
48. Estour, B., Van Herle, A.J., Juillard, G.J.F., Totanes, T.L., Sparkes, R.S., Giuliano, A.E. and Klandorf, H. (1989) Characterisation of a human follicular thryoid carcinoma cell line (UCLA RO82 W-1). Virchows Arch. B Cell Pathol. 57, 167-174.
49. Goretzki, P., Grussendorf, M., Frilling, A., Simon, D. and Roger, H.D. (1989) Permanent cell line (FTC-I 33) from a differentiated follicular human thyroid cancer. Ann. Endocrinol. (Paris) 50, 145.